India's health ministry bans pioglitazone, metamizole, and flupentixol-melitracen.

BMJ (Clinical research ed.)

Volumn 347, Issue , 2013, Pages

  Bhaumik, Soumyadeep ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTHRACENE DERIVATIVE; ANTIDIABETIC AGENT; DIPYRONE; FLUPENTIXOL; FLUPENTIXOL, MELITRACEN DRUG COMBINATION; PIOGLITAZONE;

DRUG COMBINATION; DRUG CONTROL; HUMAN; INDIA; NOTE;

ANTHRACENES; DIPYRONE; DRUG AND NARCOTIC CONTROL; DRUG COMBINATIONS; FLUPENTHIXOL; HUMANS; HYPOGLYCEMIC AGENTS; INDIA; THIAZOLIDINEDIONES;

EID: 84883563357     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f4366     Document Type: Note

References (0)